Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Investor Investigation Over Concerning Violations Of Securities Laws Announced

If you purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Alexion Pharmaceuticals
Affected Securities: 
NASDAQ: ALXN

June 5, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares over potential securities laws violations by Alexion Pharmaceuticals, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning whether a series of statements by Alexion Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 8, 2017, Alexion Pharmaceuticals' São Paulo offices were raided as part of an investigation into the Company's business practices. According to local law enforcement officials, Alexion Pharmaceuticals, Inc. may be involved in a scheme wherein the Company, with the aid of a local patient association, subsidized lawsuits for patients to get access to the Company's drug via Brazil's national health system.

Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) declined on May 26, 2017 to $96.18 per share.